1-4 of 4
drug-induced pneumonitis
Close
Sort by
Journal Articles

A Phase 2, Randomized, Open-Label, 2-Arm Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) (TEMPO)

Reem Karmali, MD, Hagop Youssoufian, MD, Kam Sprott, PhD, David T. Weaver, PhD, Narayana Narasimhan, Stephanie Lustgarten, PhD, Gloria Patrick, Alena Zalutskaya, Leo I. Gordon, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5251.
https://doi.org/10.1182/blood-2019-124406
Published: 2019
Journal Articles

Altered Expression of Functional Proteins in CD4 Regulatory T Cells during Therapy with Idelalisib

Tiago R Matos, MD MSc, Benjamin L Lampson, MD PhD, Masahiro Hirakawa, MD PhD, Siddha Kasar, PhD, Stacey M. Fernandes, Jennifer R. Brown, MD PhD, Jerome Ritz, MD
Journal: Blood
Blood (2015) 126 (23): 1735.
https://doi.org/10.1182/blood.V126.23.1735.1735
Published: 2015
Journal Articles

A Phase I Study of Gemcitabine and Bendamustine in Relapsed/Refractory Hodgkin Lymphoma

Jonathon B. Cohen, MD, Lai Wei, PhD, Kami J. Maddocks, MD, Leonard T. Heffner, MD, Amelia Langston, MD, Christopher Flowers, MD, Steven M. Devine, MD, Kristie A. Blum, MD
Journal: Blood
Blood (2015) 126 (23): 1496.
https://doi.org/10.1182/blood.V126.23.1496.1496
Published: 2015
Journal Articles

Treatment of Patients with Autoimmune Cytopenia and Progressive CLL Using Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP).

Clive S. Zent, MD, Deborah Bowen, Timothy G Call, MD, Tait D. Shanafelt, M.D., Neil E. Kay, MD, Susan L Slager, PhD, Susan Schwager, Kari Rabe, Megan Reinalda
Journal: Blood
Blood (2009) 114 (22): 4410.
https://doi.org/10.1182/blood.V114.22.4410.4410
Published: 2009